
nPhase, Inc. pioneers clinical research technology that connects clinical trial and real-world data into a single foundation for clinical decision-making. Its flagship enterprise platform, nPhase.ai, unifies and governs clinical data to provide an AI-ready foundation for pharmaceutical sponsors and CROs. Through its Statistical Computing Environment and Unified Data Management System, nPhase delivers an integrated architecture spanning the entire clinical data lifecycle, from data acquisition through regulatory submission. REDCap Cloud EDC serves small and mid-size sponsors, nonprofit and academic research organizations, MedTech studies and real-world data programs.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/02/26 | $30,000,000 | Series D |
Viking Global Investors![]() | undisclosed |